HCPCS Code Q5117
Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg
| Short Description | Inj., kanjinti, 10 mg |
|---|---|
| Year | 2026 |
| Coverage Code | C = Carrier judgment |
| Action Code | N = No maintenance for this code |
| Action Effective Date | October 01, 2019 |
| Code Added Date | October 01, 2019 |
| Pricing Indicator | 51 = Drugs |
| Type of Service | 1 = Medical care P = Lump sum purchase of DME, prosthetics, orthotics |